Covered recipient · General Payments record
UTKARSH ACHARYA
Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology
General Payments · PY2018–2023
$23,971.90
- Reported across 44 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $136.13 | 6 |
| Education | $99.99 | 1 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Exelixis Inc. | $99.99 | 1 |
| PharmaEssentia USA Corporation | $55.81 | 2 |
| Blueprint Medicines Corporation | $25.77 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $21.28 | 1 |
| Incyte Corporation | $19.91 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $13.36 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (7)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Blueprint Medicines Corporation | $25.77 | 06/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1051273327 | CMS |
| Exelixis Inc. | $99.99 | 06/05/2023 | Education | Undisputed | 01/23/2026 | 1044565827 | CMS |
| Incyte Corporation | $19.91 | 06/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1044542809 | CMS |
| Novartis Pharmaceuticals Corporation | $21.28 | 06/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 991686295 | CMS |
| PharmaEssentia USA Corporation | $40.62 | 06/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1059315131 | CMS |
| PharmaEssentia USA Corporation | $15.19 | 10/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1059315235 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $13.36 | 05/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1055324757 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.